HUP0103960A3 - Methods of downmodulating the immune response to therapeutic proteins - Google Patents

Methods of downmodulating the immune response to therapeutic proteins

Info

Publication number
HUP0103960A3
HUP0103960A3 HU0103960A HUP0103960A HUP0103960A3 HU P0103960 A3 HUP0103960 A3 HU P0103960A3 HU 0103960 A HU0103960 A HU 0103960A HU P0103960 A HUP0103960 A HU P0103960A HU P0103960 A3 HUP0103960 A3 HU P0103960A3
Authority
HU
Hungary
Prior art keywords
downmodulating
methods
immune response
therapeutic proteins
proteins
Prior art date
Application number
HU0103960A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Genetics Inst Llc Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst Llc Cambridge filed Critical Genetics Inst Llc Cambridge
Publication of HUP0103960A2 publication Critical patent/HUP0103960A2/hu
Publication of HUP0103960A3 publication Critical patent/HUP0103960A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU0103960A 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins HUP0103960A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15817898A 1998-09-21 1998-09-21
PCT/US1999/021991 WO2000016801A1 (fr) 1998-09-21 1999-09-21 Methodes de modulation restrictive de la reponse immunitaire aux proteines therapeutiques

Publications (2)

Publication Number Publication Date
HUP0103960A2 HUP0103960A2 (hu) 2002-02-28
HUP0103960A3 true HUP0103960A3 (en) 2003-09-29

Family

ID=22566971

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103960A HUP0103960A3 (en) 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins

Country Status (21)

Country Link
EP (1) EP1115423A1 (fr)
JP (1) JP2002526455A (fr)
KR (1) KR20010085830A (fr)
CN (1) CN1331602A (fr)
AU (1) AU761206B2 (fr)
BR (1) BR9913991A (fr)
CA (1) CA2343916A1 (fr)
CZ (1) CZ20011021A3 (fr)
EA (1) EA005236B1 (fr)
HK (1) HK1039059A1 (fr)
HU (1) HUP0103960A3 (fr)
IL (1) IL142069A0 (fr)
LT (1) LT4920B (fr)
LV (1) LV12768B (fr)
MX (1) MXPA01002898A (fr)
NO (1) NO20011412L (fr)
NZ (1) NZ511034A (fr)
PL (1) PL346796A1 (fr)
SI (1) SI20626A (fr)
WO (1) WO2000016801A1 (fr)
ZA (1) ZA200103156B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
WO2001089564A2 (fr) * 2000-05-19 2001-11-29 The Center For Blood Research, Inc. Procedes pour diagnostiquer et traiter des troubles hemostatiques par modulation de l'activite de la p-selectine
JP2007516509A (ja) * 2003-06-10 2007-06-21 スミスズ ディテクション インコーポレイティド センサ装置
GB201508024D0 (en) 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171569A (en) 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
JPH0788399B2 (ja) 1985-04-12 1995-09-27 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新規プロコアギュラント蛋白質
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (fr) 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
US5770197A (en) 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
JP3722375B2 (ja) 1991-06-27 2005-11-30 ブリストル−マイヤーズ スクイブ カンパニー Ｃｔｌａ４レセプター、それを含有する融合タンパク質およびそれらの使用
WO1993009804A1 (fr) 1991-11-18 1993-05-27 The Scripps Research Institute Polypeptides derives de la serine protease et anticorps anti-peptidiques, systemes et procedes therapeutiques empechant la coagulation du sang
US5744446A (en) 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5364771A (en) 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5663060A (en) 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
EP0776217A1 (fr) * 1994-08-19 1997-06-04 Novo Nordisk A/S Methode de traitement d'un patient a l'aide d'un compose biologiquement actif
EP0804076A4 (fr) * 1994-10-19 1998-10-21 Genetic Therapy Inc Therapie genique par administration concurrente et repetee d'adenovirus et d'agents immunodepresseurs
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
US5916560A (en) * 1996-03-20 1999-06-29 Bristol-Myers Squibb Company Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith
BR9807471A (pt) * 1997-01-10 2000-03-21 Biogen Inc Uso do composto anti-cd40l
BR9810755A (pt) * 1997-06-20 2000-08-15 Biogen Inc Terapia de bloqueio de cd 154 para a sìndrome inibidora de proteìna terapêutica
US8151477B2 (en) 2009-11-06 2012-04-10 Hexagon Metrology Ab CMM with modular functionality

Also Published As

Publication number Publication date
WO2000016801A1 (fr) 2000-03-30
EP1115423A1 (fr) 2001-07-18
CN1331602A (zh) 2002-01-16
LV12768A (en) 2001-12-20
EA200100385A1 (ru) 2001-10-22
NZ511034A (en) 2004-03-26
LT4920B (lt) 2002-06-25
HK1039059A1 (zh) 2002-04-12
AU761206B2 (en) 2003-05-29
WO2000016801A9 (fr) 2000-10-26
BR9913991A (pt) 2001-07-03
LT2001045A (en) 2002-01-25
JP2002526455A (ja) 2002-08-20
PL346796A1 (en) 2002-02-25
ZA200103156B (en) 2002-07-18
KR20010085830A (ko) 2001-09-07
NO20011412D0 (no) 2001-03-20
SI20626A (sl) 2002-02-28
HUP0103960A2 (hu) 2002-02-28
MXPA01002898A (es) 2002-06-04
IL142069A0 (en) 2002-03-10
AU6057899A (en) 2000-04-10
LV12768B (lv) 2002-06-20
CZ20011021A3 (cs) 2001-10-17
CA2343916A1 (fr) 2000-03-30
NO20011412L (no) 2001-05-16
EA005236B1 (ru) 2004-12-30

Similar Documents

Publication Publication Date Title
AP2000001983A0 (en) Antibodies to cd23 derivatives thereof and their therapeutic uses
IL132318A0 (en) Substituted imidazoles useful in the treatment of inflammatory diseases
IL135673A0 (en) Therapeutic uses of quinoline derivatives
EP1033994A4 (fr) Methodes de preparation de bioginko
ID28441A (id) Terapi untuk memperbaiki kesadaran
FI964193A (fi) Puriinien valmistaminen
IL133088A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
ZA984177B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
GB9930443D0 (en) Novel use of heat shock proteins
PL346796A1 (en) Methods of downmodulating the immune response to therapeutic proteins
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
FI953580A (fi) Asyklovirin valmistus
GB9822619D0 (en) Immune response stimulation
DE29820137U1 (de) Multifunktionales Kindermöbel
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
DE9400033U1 (de) Massagekugel
GB9727410D0 (en) Improvements relating to adjustable furniture
GB9727230D0 (en) Improvements relating to adjustable furniture
KR960025637U (ko) 간격조절이 용이한 콘넥터
NO965332D0 (no) Terapeutisk perparat
KR960013110U (ko) 신발의 바닥면에 착탈이 용이한 지압구
GB9606255D0 (en) The game of bridge companion
TW322782U (en) Structure improvement of walker
TW351186U (en) Improvement of exercise walker
TW369896U (en) Modified walker structure